Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

327 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
What is the optimal dose of botulinum toxin A in the treatment of cervical dystonia? Results of a double blind, placebo controlled, dose ranging study using Dysport. German Dystonia Study Group.
Poewe W, Deuschl G, Nebe A, Feifel E, Wissel J, Benecke R, Kessler KR, Ceballos-Baumann AO, Ohly A, Oertel W, Künig G. Poewe W, et al. Among authors: benecke r. J Neurol Neurosurg Psychiatry. 1998 Jan;64(1):13-7. doi: 10.1136/jnnp.64.1.13. J Neurol Neurosurg Psychiatry. 1998. PMID: 9436721 Free PMC article. Clinical Trial.
Botulinum toxin: from poison to remedy.
Kessler KR, Benecke R. Kessler KR, et al. Among authors: benecke r. Neurotoxicology. 1997;18(3):761-70. Neurotoxicology. 1997. PMID: 9339823 Review.
Pallidal neurostimulation in patients with medication-refractory cervical dystonia: a randomised, sham-controlled trial.
Volkmann J, Mueller J, Deuschl G, Kühn AA, Krauss JK, Poewe W, Timmermann L, Falk D, Kupsch A, Kivi A, Schneider GH, Schnitzler A, Südmeyer M, Voges J, Wolters A, Wittstock M, Müller JU, Hering S, Eisner W, Vesper J, Prokop T, Pinsker M, Schrader C, Kloss M, Kiening K, Boetzel K, Mehrkens J, Skogseid IM, Ramm-Pettersen J, Kemmler G, Bhatia KP, Vitek JL, Benecke R; DBS study group for dystonia. Volkmann J, et al. Among authors: benecke r. Lancet Neurol. 2014 Sep;13(9):875-84. doi: 10.1016/S1474-4422(14)70143-7. Epub 2014 Aug 7. Lancet Neurol. 2014. PMID: 25127231 Clinical Trial.
Dose standardization of botulinum toxin.
Krack P, Deuschl G, Benecke R, Ceballos-Baumann AO, Marion MH, Oertel WH, Poewe W. Krack P, et al. Among authors: benecke r. Mov Disord. 1998 Jul;13(4):749-51. doi: 10.1002/mds.870130425. Mov Disord. 1998. PMID: 9686787 No abstract available.
A randomized, double-blind, placebo-controlled, dose-ranging study to compare the efficacy and safety of three doses of botulinum toxin type A (Dysport) with placebo in upper limb spasticity after stroke.
Bakheit AM, Thilmann AF, Ward AB, Poewe W, Wissel J, Muller J, Benecke R, Collin C, Muller F, Ward CD, Neumann C. Bakheit AM, et al. Among authors: benecke r. Stroke. 2000 Oct;31(10):2402-6. doi: 10.1161/01.str.31.10.2402. Stroke. 2000. PMID: 11022071 Clinical Trial.
327 results